We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Stem Cell Differentiation Controlled by Two Related Proteins

By Biotechdaily staff writers
Posted on 29 Jul 2003
Researchers have identified the mechanism that controls whether hematopoetic stem cells (HSC) remain undifferentiated or whether they transform into one of eight specialized types of blood cells.

Investigators at the University of Wisconsin (Madison, USA) studied the interaction of the GATA transcription factors, which are known to be important determinants of cell fate during hematopoiesis. More...
They used chromatin immunoprecipitation analysis to show that the GATA-1 protein bound to a highly restricted upstream region of the 70-kb GATA-2 domain, despite the presence of more than 80 GATA sites throughout the domain. GATA-2 also bound to this region in the absence of GATA-1. Genetic complementation studies in GATA-1-null cells showed that GATA-1 rapidly displaced GATA-2, which was coupled to transcriptional repression. GATA-1 also displaced CREB-binding protein (CBP), despite the fact that GATA-1 bound CBP in other contexts. These findings were published July 11, 2003, in the online edition of the Proceedings of the National Academy of Sciences.

"Manipulations to expand stem cell numbers can cause the cells to lose their ability to remain stem cells,” explained senior author Dr. Emery Bresnick, professor of pharmacology at the University of Wisconsin. "Any mechanism that tells you how to maintain stem cell status and prevent differentiation is a good target for modulating and improving this whole process. We discovered a mechanism that is an excellent candidate for controlling the decision of whether the HSC should remain undifferentiated or form blood. It is a delicate balance between two highly related proteins, but if we can shift the balance by modulating this relationship, we can chose to increase the number of these limited HSC or stimulate hematopoiesis.”




Related Links:
University of Wisconsin

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: POC fingerstick blood testing enables faster hepatitis B DNA testing outside centralized laboratories (Photo courtesy of Conor Ashleigh)

POC Testing for Hepatitis B DNA as Effective as Traditional Laboratory Testing

Hepatitis B is a viral infection that attacks the liver and can lead to cirrhosis, liver failure, and liver cancer over time. Despite being preventable through vaccination and treatable in its chronic... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.